Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The FOURTH Markman???....not unusual
13
Jan 08, 2013 12:50PM
12
opc
Jan 08, 2013 06:32PM
7
opc
Jan 09, 2013 12:21AM
14
Jan 09, 2013 01:41AM
5
Jan 09, 2013 03:25PM
9
Jan 09, 2013 04:00PM
4
Jan 09, 2013 04:26PM
1
opc
Jan 09, 2013 05:18PM
7
Jan 09, 2013 07:29PM

opc
Jan 09, 2013 07:46PM
7
Jan 10, 2013 03:53PM
2
Jan 10, 2013 04:02PM
9
Jan 10, 2013 04:07PM
2
Jan 10, 2013 04:14PM
3
Jan 10, 2013 04:14PM

...As a result, now that the ruling from the NDCA is final, there would be no reason for the Company to refrain from releasing a PR based on that ruling itself...

ron, thanks you explained a lot in the past, not that i do understand it completely, but,

what if leckrone has a different view than you, or at least what if leckrone stopps any pr because of playing his game of delay, for various reasons (moore, brown, pds to pay him etc.)

would then, issuing a pr by ptsc, in opposition to leckrone, this potentially mean breach of the comag, or the master agreement?

could this be a reason not to pr the ndca 2nd markman?

2
opc
Jan 10, 2013 10:39PM

Jan 10, 2013 10:46PM
2
Jan 11, 2013 05:53AM
1
opc
Jan 11, 2013 06:59AM
7
Jan 11, 2013 10:46AM

opc
Jan 11, 2013 08:05PM
Share
New Message
Please login to post a reply